Physician profile
Gary A Stephens
NPI 1386750289
$2,227.13
in general payments reported to CMS, 2019-2025
10 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $183 · 2021: $816 · 2022: $143 · 2023: $299 · 2024: $185 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $646.67 | 2019-2022 | |
| Atricure, INC. | $485.71 | 2021 | |
| Edwards Lifesciences Corporation | $470.67 | 2020-2025 | |
| Abiomed | $244.91 | 2019-2023 | Impella |
| Terumo Medical Corporation | $125.00 | 2020 | |
| Cook Medical LLC | $100.78 | 2023-2025 | Cook, Zenith Alpha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.21 | 2019-2022 | |
| Bolton Medical INC | $35.30 | 2019 | |
| Zimmer Biomet Holdings, INC. | $16.25 | 2025 | Venapax, Cable-Ready, A&E Medical / Sternalock Xp Rigid Fixation System |
| Biomerieux INC | $14.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.